The approach consisted of the adoptive transfer of preconditioned donor-type Tregs that were in vitro exposed to irradiated peripheral blood cells from acute GvHD recipients (cytokine primed) or primed with TNF in the presence of IL-2. The gene discussed is TNF; the disease is graft versus host disease.